FIELD: medicine, ophthalmology.
SUBSTANCE: method involves administration of chitosan sponge with square up to 2 cm2 into sub-Tenon's space wherein chitosan sponge shows the deacetylation degree 98%, its molecular mass is 1000 kDa and it comprises 2.8 x 10-9 g of hyaluronic acid, 27.8 x 10-8 g of chondroitinsulfuric acid, 3.06 x 10-11 g of cattle serum growth factor and 7 x 10-9 g of heparin per 1 mm2 of chitosan sponge. Method provides stabilizing visual function, to improving vision and expanding vision field based on enhancing sensitivity of optic nerve as result of blood stream enhancing. Invention can be used in treatment of progressing glaucoma with non-stabilizing functions.
EFFECT: improved method of treatment.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING DEGENERATIVE MYOPIA | 2006 |
|
RU2308952C1 |
METHOD FOR PROPHYLAXIS OF MYOPIA PROGRESSING | 2005 |
|
RU2275917C1 |
METHOD FOR TREATING OPTIC NERVE ATROPHY CASES | 2006 |
|
RU2309749C1 |
METHOD FOR TREATMENT OF DIABETIC RETINOPATHY WITH PREPARATION "BOL-KHIT" | 2006 |
|
RU2301675C1 |
METHOD FOR TREATMENT OF CENTRAL ATHEROSCLEROTIC CHORIORETINOPATHY | 2005 |
|
RU2281775C1 |
METHOD FOR COMBINED LASER TREATMENT OF PRIMARY OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2820310C1 |
METHOD OF SELECTING PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA FOR SELECTIVE LASER TRABECULOPLASTY | 2019 |
|
RU2726462C1 |
METHOD FOR SURGICAL TREATMENT OF GLAUCOMA BY RESECTION OF SCLERA | 2015 |
|
RU2587856C1 |
METHOD OF TREATING GLAUCOMA | 1990 |
|
RU2022539C1 |
METHOD OF MEASURED STABILISATION OF INTRAOCULAR PRESSURE DURING MICROINVASIVE ANTIGLAUCOMA OPERATION | 2007 |
|
RU2344796C1 |
Authors
Dates
2007-05-27—Published
2005-12-06—Filed